First International Bank & Trust Sells 115 Shares of Aflac Incorporated (NYSE:AFL)

First International Bank & Trust decreased its position in shares of Aflac Incorporated (NYSE:AFL) by 3.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,626 shares of the financial services provider’s stock after selling 115 shares during the period. First International Bank & Trust’s holdings in Aflac were worth $405,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of AFL. Strategic Financial Concepts LLC increased its position in Aflac by 7,001.0% in the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock valued at $596,000 after acquiring an additional 658,303 shares in the last quarter. Truist Financial Corp increased its holdings in shares of Aflac by 26.6% in the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after purchasing an additional 405,847 shares in the last quarter. Swedbank AB bought a new position in Aflac in the 1st quarter worth approximately $27,588,000. Schroder Investment Management Group lifted its holdings in Aflac by 196.5% during the 4th quarter. Schroder Investment Management Group now owns 484,176 shares of the financial services provider’s stock worth $39,945,000 after buying an additional 320,867 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Aflac by 6.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after buying an additional 285,576 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Up 1.5 %

AFL traded up $1.73 during trading on Friday, reaching $115.26. The company had a trading volume of 1,717,703 shares, compared to its average volume of 2,255,626. The company has a market cap of $65.49 billion, a P/E ratio of 12.72, a PEG ratio of 2.60 and a beta of 0.95. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.10. The business’s fifty day moving average price is $106.42 and its 200 day moving average price is $93.94.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.60 by $0.23. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The firm’s revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.58 EPS. Equities analysts anticipate that Aflac Incorporated will post 6.75 EPS for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.74%. Aflac’s dividend payout ratio is currently 22.08%.

Insider Buying and Selling

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.90% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Morgan Stanley upped their price target on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research note on Monday, August 19th. Truist Financial increased their price objective on shares of Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a report on Friday, August 2nd. UBS Group lifted their target price on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Barclays began coverage on Aflac in a research note on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price target on the stock. Finally, Jefferies Financial Group decreased their price objective on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aflac currently has an average rating of “Hold” and a consensus target price of $95.43.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.